Back

Histologic remission and major adverse cardiovascular events in patients with inflammatory bowel disease: a nationwide cohort study

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Insights into incident heart failure Epidemiology, Prognosis, Outcome ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Jiangwei Sun

Karolinska Institute, Stockholm (Sweden)

4 More presentations in this session

Presentation thumbnail
Risk of heart failure by blood pressure level in patients with hypertension in primary care
Doctor J. Bager (Gothenburg, SE)
Abstract Slides Video
Presentation thumbnail
Longer menstruation, lower heart failure risk: impacts of endogenous and exogenous hormone exposure in women
Ms E. Shalowitz (Aurora, US) Miss K. Sompel (Aurora, US)
Abstract Slides Video
Presentation thumbnail
Coronary microvascular dysfunction associated with increased risk of Heart Failure
Mr R. Haahr (Frederiksberg, DK)
Abstract Slides Video
Presentation thumbnail
One-year clinical outcomes of NSTEMI patients according to left ventricular ejection fraction: data from a large multicenter registry.
Doctor L. Spadafora (Latina, IT)
Abstract Slides Video

Access the full session

Session thumbnail
Insights into incident heart failure

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Advanced biologic therapies are associated with fewer adverse cardiovascular events in patients with inflammatory bowel diseases
thumbnail
Congress Presentation
Dysbiotic microbiome induce cardiac impairment by attenuating brain-derived neurotrophic factor in inflammatory bowel diseases
thumbnail
Congress Presentation
Risk of cardiovascular diseases in irritable bowel syndrome patients

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources